Bosh sahifaSHTDY • OTCMKTS
add
Sinopharm Group ADR
Yopilish kursi
11,68 $
Kunlik diapazon
11,70 $ - 11,80 $
Yillik diapazon
10,13 $ - 16,31 $
Bozor kapitalizatsiyasi
57,12 mlrd HKD
Oʻrtacha hajm
17,22 ming
Bozor yangiliklari
Moliyaviy axborot
Moliyaviy hisobot
Daromad
Sof foyda
| (CNY) | mar, 2025info | Y/Y qiyosi |
|---|---|---|
Daromad | 141,66 mlrd | -3,81% |
Joriy xarajat | 6,72 mlrd | -6,59% |
Sof foyda | 1,46 mlrd | 2,59% |
Sof foyda marjasi | 1,03 | 7,29% |
Har bir ulushga tushum | — | — |
EBITDA | 3,70 mlrd | -5,19% |
Amaldagi soliq stavkasi | 23,38% | — |
Balans
Jami aktivlari
Jami passivlari
| (CNY) | mar, 2025info | Y/Y qiyosi |
|---|---|---|
Naqd pul va qisqa investitsiyalar | 45,36 mlrd | -32,44% |
Jami aktivlari | 415,08 mlrd | — |
Jami passivlari | 285,93 mlrd | — |
Umumiy kapital | 129,16 mlrd | — |
Tarqatilgan aksiyalar | 3,12 mlrd | — |
Narxi/balansdagi bahosi | 0,45 | — |
Aktivlardan daromad | 1,96% | — |
Kapitaldan daromad | 3,85% | — |
Pul aylanmasi
Naqd pulning sof oʻzgarishi
| (CNY) | mar, 2025info | Y/Y qiyosi |
|---|---|---|
Sof foyda | 1,46 mlrd | 2,59% |
Operatsiyalardan naqd pul | -34,28 mlrd | 27,81% |
Sarmoyadan naqd pul | 617,49 mln | 141,09% |
Moliyadan naqd pul | 12,88 mlrd | -41,88% |
Naqd pulning sof oʻzgarishi | -20,78 mlrd | 17,10% |
Boʻsh pul | -14,13 mlrd | — |
Haqida
Sinopharm Group Co., Ltd. is a Chinese pharmaceutical company. The parent company of Sinopharm Group was Sinopharm Industrial Investment, a 51–49 joint venture of state-owned enterprise China National Pharmaceutical Group and civilian-run enterprise Fosun Pharmaceutical.
Its H shares were listed on the Hong Kong Stock Exchange in 2009, with its IPO price of HK$16 per share. Sinopharm Group's subsidiary Sinopharm CNMC and Sinopharm Accord served as the A share counterpart of the company. However, the A share of Sinopharm Group itself was unlisted.
Sinopharm Group was ranked 829th in 2016 Forbes Global 2000 list. Wikipedia
Tashkil etilgan
2003
Sayt
Xodimlar soni
108 217
